Emory Eye Center

Universal Navigation

• Emory University |
• Emory Healthcare |
• Woodruff Health Sciences Center

• Emory Sites
• People Directory

• News Releases

  Emory Eye Center to Host 26th Southeastern Vitreoretinal Seminar (SEVR)
  Jan. 12, 2012 | (ATLANTA) Emory Eye Center will host the 26th Southeastern Vitreoretinal Seminar (SEVR) at the Eye Center’s Calhoun Auditorium within the Learning Resources Center in The Emory Clinic, Building B. The meeting will take place from 8 a.m. to 5 p.m. on Friday, February 17, 2012. The annual seminar addresses issues of the retina and treatments for its various disorders.

  Startup Receives $4 Million to Develop Drug Delivery Targeted to the Back of the Eye
  Jan. 5, 2012 | (ATLANTA) Technology developed by researchers at the Georgia Institute of Technology and Emory University for delivering drugs and other therapeutics to specific locations in the eye provides the foundation for a startup company that has received a $4 million venture capital investment.

  Seven Top Ophthalmologists at Emory
  (ATLANTA) Seven physicians at Emory Eye Center were selected among the top ophthalmologists in the country in a ranking published in U.S. News & World Report. ™. Its directory includes more than 27,000 top physicians in dozens of medical specialties.

  Emory Eye Center Researcher Co-editor of New Textbook on Drug Delivery to the Back of the Eye
  Sept. 30, 2011 | (ATLANTA) A new textbook, Drug Product Development for the Back of the Eye (aapspress/Springer), edited by Emory Eye Center researcher Henry F. Edelhauser, PhD and Uday B. Kompella, PhD, of the University of Colorado, explores approaches for a delivery system to get drugs to the back of the eye. In the past, drug delivery was typically systemic and not targeted to where it might do the most good for the particular ophthalmic disease and disorder.

  Emory Eye Center To Host Second Annual Southeastern Ocular Oncology/Pathology Seminar
  September 19, 2011 | (ATLANTA) Emory Eye Center will host the second annual Southeastern Ocular Oncology/Pathology seminar (SEOP) on Friday, Sept. 30, at the Eye Center's Learning Resources Center, Calhoun Auditorium, from 8 a.m. to 5 p.m. The seminar is designed for primary care physicians, ophthalmologists and oncologists interested in increasing knowledge in identifying and treating ocular malignancies and in how to apply this knowledge to clinical practice.

  Three Emory Eye Center physicians honored in "135 Leading Ophthalmologists in America" listing
  August 25, 2011 | (ATLANTA) Maria M. Aaron, MD, Timothy W. Olsen, MD and J. Bradley Randleman, MD were elected to Becker’s Ambulatory Surgery Centers (ASC) Review’s “135 Leading Ophthalmologists in America” list. Honorees are selected based on the awards they have received from major organizations in the field, leadership in those organizations, work on professional publications and their positions of service. 

   

  View all news releases »

  
  

  Making Headlines

  January 13, 2012 | Atlanta Business Chronicle, Startup Clearside Biomedical raises $4 million. Biotech startup Clearside Biomedical Inc. has raised $4 million from Hatteras Venture Partners. The Atlanta-based company has developed a microneedle technology that allows an eye surgeon to deliver medication to a specific part of the retina. The proprietary technology, licensed from Georgia Tech and Emory University, is designed to nonsurgically deliver drugs to an area of the eye referred to as the supra choroidal space, located at the back of the retina, Clearside Biomedical CEO Daniel White said.

  January 6, 2012 | MedicalXpress.com, Startup receives $4 million to develop drug delivery targeted to the back of the eye . The technology was developed in collaboration between the research groups in Georgia Tech's School of Chemical and Biomolecular Engineering, and Henry Edelhauser, a professor in the Department of Ophthalmology at Emory School of Medicine. Research leading to development of the technology was sponsored by the National Institutes of Health (NIH).

  September 26, 2011 | WebMD Video , Click on "Eyes", answer the question and click "continue" then click on "Protecting Your Sight from Diabetes" (under Related Content). Timothy W. Olsen, MD, F. Phinizy Calhoun Sr. Professor of Ophthalmology and director of Emory Eye Center, was interviewed about diabetes and the eyes. The disease is the leading cause of new cases of blindness in people under 50 in the United States. Patient Henry Bryan was also interviewed about how he has taken control of his diabetes over the years and the importance of controlling blood glucose levels. His retinopathy has regressed as a result of his careful monitoring, and his vision today is very good.

  September 20, 2011 | "Intracranial hypertension: its diagnosis, treatment, and consequences."  Listen:  Beau Bruce, MD . Our brains are bathed in fluid that helps protect them from trauma. But sometimes—for unknown reasons—the pressure can become abnormally elevated. This condition, known as idiopathic intracranial hypertension, can lead to headaches, double vision, and even vision loss. The disease affects primarily obese women of childbearing age but can affect anyone. Listen as Emory neuro-ophthalmologist Beau Bruce, MD, talks about idiopathic intracranial hypertension, its treatment, and about a new way that may help diagnose it earlier and in more people.

• Find Us On

  Twitter	YouTube
  Facebook	iTunesU

• ophthaL. events CALENDAR »
• 
• 
•